News for Healthier Living

UT MD Anderson Shares Latest Research Breakthroughs

* Phase 3 results show promise for new immunotherapy advanced lung cancer * Researchers find new role for B7-H3 in cancer immunity and a combination approach that improved outcomes in preclinical models of prostate cancer * Insights suggest which patients are most likely to benefit from CAR T cell therapy and that many patients with appendix cancer could avoid chemotherapy * Blood tests could monitor bone metastases in patients with medullary thyroid cancer * Scientists make advances in detecting risk of and treatment for immunotherapy-related colitis and treatment-induced lung inflammation

September 25, 2026


September 25 2026

September 24 2026

September 23 2026

September 22 2026

September 21 2026

September 18 2026

September 17 2026

September 16 2026

September 15 2026

September 14 2026

September 11 2026